Kringle Pharma, Inc. (TYO:4884)
Japan · Delayed Price · Currency is JPY 500.00
-5.00 (-0.99%)
Aug 1, 2025, 3:30 PM JST
Kringle Pharma Revenue
Kringle Pharma had revenue of 16.84M JPY in the quarter ending March 31, 2025, a decrease of -32.64%. This brings the company's revenue in the last twelve months to 72.00M, down -7.69% year-over-year. In the fiscal year ending September 30, 2024, Kringle Pharma had annual revenue of 80.00M with 15.94% growth.
Revenue (ttm)
72.00M
Revenue Growth
-7.69%
P/S Ratio
47.48
Revenue / Employee
4.80M
Employees
15
Market Cap
3.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 80.00M | 11.00M | 15.94% |
| Sep 30, 2023 | 69.00M | -322.00M | -82.35% |
| Sep 30, 2022 | 391.00M | 102.00M | 35.29% |
| Sep 30, 2021 | 289.00M | -178.00M | -38.12% |
| Sep 30, 2020 | 467.00M | - | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Otsuka Holdings | 2,393.18B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |